References(56)
2.
Murugan V. Embryonic stem cell research: a decade of debate from Bush to Obama. Yale J Biol Med. 2009;82(3):101-103.
3.
Lawrence, DJ. The four principles of biomedical ethics: a foundation for current bioethical debate. J Chiropr Humanit. 2007;(14):34-40.
4.
Sabbatani S. The infectious diseases experiments conducted on human guinea pigs by Nazis in concentration camp. Infez Med. 2013;21(2):151-166.
5.
Vargesson N. Thalidomide-induced teratogenesis: History and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140-56.
6.
Sackett DL, Rosenberg W, Gray JA, Haynes RB, Richardson, WS. Evidence based medicine: what it is and what it isn’t. British Med J. 1996;312(7023):71-72.
7.
Melnyk BM, Fineout-Overholt E, Stillwell SB, Williamson KM. Evidence-based practice: step by step: the seven steps of evidence-based practice. AJN. 2010;110(1):51-53.
8.
Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticisms of evidence-based medicine. Intl J Med Informatics. 2004;73(1):35-43.
9.
Klees JE, Joines R. Occupational health issues in the pharmaceutical research and development process. Occup Med. 1996;12(1):5-27.
10.
Lipsky MS, Sharp LK. From idea to market: the drug approval process. J Am Board Fam Pract. 2001;14(5):362-367.
11.
Huang H, Xi H, Chen L, Zhang F, Liu Y. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant. 2012;21(Suppl 1):S23-S31.
12.
Saberi H, Moshayedi P, Aghayan HR et al. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett. 2008;443(1):46-50.
13.
Moviglia GA, Varela G, Brizuela JA, et al. Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord. 2009;47(6):499-503.
14.
Sharma A, Sane H, Gokulchandran N et al. Role of autologous bone marrow mononuclear cells in chronic cervical spinal cord injury-a long term follow up study. J Neurol Disord. 2013;1:138.
15.
Sharma A, Gokulchandran N, Sane H et al. Detailed analysis of the clinical effects of cell therapy for thoracolumbar spinal cord injury: an original study. J Neurorest. 2013;1:13-22.
16.
Tabakow P, Jarmundowicz W, Czapiga B et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell transplant. 2013;22(9):1591-1612.
17.
Sharma A, Sane H, Gokulchandran N et al. Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke. Stroke Res Treat. 2014;2014:234095.
18.
Li ZM, Zhang ZT, Guo CJ, Geng FY, Qiang F, Wang LX. Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage-a prospective clinical observation. Clin Neurol Neurosurg. 2013;115(1):72-76.
20.
Nabar NR, Yuan F, Lin X, et al. Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer’s disease in APP+PS1 mice. PLoS One. 2012;7(12):e49468.
21.
Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A. 2009;106(32):13594-13599.
22.
Gorba T, Harper S, Mee PJ. Prospects for neural stem cell therapy of Alzheimer disease. J Stem Cells Regen Med .2011:337-348.
23.
Sharma A, Badhe P, Gokulchandran N et al. Autologous Bone Marrow Derived Mononuclear Cell Therapy for Vascular Dementia. J Stem Cell Res Ther .2011;2(129):2.
24.
Martínez HR, Molina-Lopez JF, González-Garza MT, et al. Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility. Cell Transplant. 2012;21(9):1899-1907.
25.
Mazzini L, Mareschi K, Ferrero I, et al. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy. 2012;14(1):56-60.
26.
Mazzini L, Ferrero I, Luparello V et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. J Exp Neuro. 2010;223(1):229-237.
27.
Karussis D, Karageorgiou C, Vaknin-Dembinsky A et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010;67(10):1187-1194.
28.
Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E, Segura JJ. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy, 2009;11(1):26-34.
29.
Deda H, Inci MC, Kürekçi AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11(1):18-25.
30.
Blanquer M, Moraleda JM, Iniesta F, et al. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells .2012;30(6):1277-1285.
31.
Blanquer M, Pérez EM, Iniesta F, et al. Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial. Methods Find Exp Clin Pharmacol. 2010;32:31-37.
32.
Prabhakar S, Marwaha N, Lal V, Sharma RR, Rajan R, Khandelwal N. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study. Neurol India. 2012;60(5):465.
33.
Sharma AK, Sane HM, Paranjape AA, et al. The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis–a retrospective controlled study. Am J Stem Cells. March 15 2015;4(1):50-65.
34.
Huang H, Chen L, Xi H, et al. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant. 2008;22(6):710-718.
35.
Chen L, Huang H, Zhang J, et al. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo Xiu Fu Chong JianWaiKeZaZhi [Chinese journal of reparative and reconstructive surgery]. 2007;21(9):961-966.
36.
Chen L, Chen D, Xi H, et al. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations. Cell Transplant. 2012;21(Suppl 1):S65-S77.
37.
Sharma A, Gokulchandran N, Sane H, et al. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem Cells Int. 2013;2013:623875.
38.
Lv YT, Zhang Y, Liu M, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med. 2013;27(11):196.
39.
Chen L, Huang H, Xi H, et al. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial. Cell Transplant .2010;19(2):185-191.
40.
Chernykh ER, Kafanova MY, Shevela EY, et al. Autologous M2-like macrophage applications in children with cerebral palsy. Cell Ther Transpl. 2011;3:12-14.
41.
Sharma A, Sane H, Gokulchandran N, et al. A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier. Stem Cells Int. 2015;2015:905874.
42.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA: The journal of the American Medical Association. 2013;310(20):2191.
44.
Gunter KC, Caplan AL, Mason C, et al. Cell therapy medical tourism: time for action. Cytotherapy. 2010;12(8):965-968.
45.
Huang H, Raisman G, Masri WS, et al. International Association of Neurorestoratology. Beijing Declaration of International Association of Neurorestoratology (IANR). Cell Transpl .2009; 18(4):487.
46.
Horn SD, Gassaway J. Practice-based evidence study design for comparative effectiveness research. Med care. 2007;45(10):S50-S57.
47.
Green LW. Making research relevant: if it is an evidence-based practice, where’s the practice-based evidence? Family practice. 2008;25(Suppl 1):i20-i24.
48.
McDonald PW, Viehbeck S. From Evidence-Based Practice Making to Practice-Based Evidence Making Creating Communities of Research and Practice. Health Promot Pract. 2007;8(2):140-144.
49.
Timmermans S, Mauck A. The promises and pitfalls of evidence-based medicine. Health Affairs. 2005;24(1):18-28.
53.
Cyranoski D. Japan to offer fast-track approval path for stem cell therapies. Nature med. 2013;19(5):510.
55.
Santos MJ, Ventura-Juncá P. Bioethical aspects of basic research and medical applications of human stem cells. Biol Res. 2012;45(3):317-326.